HIHiroyuki Inoue

Hiroyuki Inoue

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hiroyuki Inoue has a total of 96 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Adult esophageal duplication preoperatively diagnosed by endoscopic ultrasonography and treated with thoracoscopic resection: a case report

    by Hiroyuki Inoue, Hitoshi Fujiwara, Hirotaka Konishi, Keiji Nishibeppu, Hiroki Shimizu, Tomohiro Arita, Toshiyuki Kosuga, Yusuke Yamamoto, Ryo Morimura, Atsushi Shiozaki

  • Open Access

    Prognostic Significance and Clinical Robustness of the HALP Score in Super‐Elderly Patients Undergoing Curative Gastrectomy for Gastric Cancer: A Multicenter Retrospective Cohort Study

    by Hiroyuki Inoue, Takeshi Kubota, Toshiyuki Kosuga, Keiji Nishibeppu, Shutaro Sumiyoshi, Junichi Hamada, Kazuya Takabatake, Keita Katsurahara, Yosuke Ariyoshi, Koji Miyagawa, et al.

    Background: Management of super‐elderly patients (aged ≥ 80 years) with gastric cancer (GC) has become an increasingly important clinical issue. We aimed to evaluate the prognostic significance of preoperative “hemoglobin, albumin, lymphocyte, and platelet” (HALP) scores, which may reflect both tumor‐ and host‐related conditions, in super‐elderly patients with GC. Methods: This study included 507 super‐elderly patients who underwent curative gastrectomy for GC at 10 hospitals. HALP scores were calculated as follows: hemoglobin × albumin × lymphocytes/platelets. We evaluated the prognostic significance and clinical robustness of the HALP score. Results: Preoperative HALP scores ranged from 1.628 to 289.201 (median, 50.795), and the optimal cutoff value for predicting overall survival (OS) was 42.382, based on receiver operating characteristic curve analysis. Multivariate analysis identified that male sex, high preoperative carcinoembryonic antigen levels, poor performance status, pT3/4, pN(+), and low HALP scores (hazard ratio [HR], 2.23; 95% confidence interval, 1.63–3.04; p < 0.001) were independent risk factors for poor OS. We demonstrated the robustness of the prognostic significance of the HALP score using quartile, continuous variable, leave‐one‐center‐out, and subgroup analyses. In addition, a low HALP score was independently associated with worse cancer‐specific survival (HR, 2.08) and other‐cause mortality (HR, 2.39), suggesting that the HALP score may reflect both tumor‐ and host‐related conditions in super‐elderly patients with GC. Conclusion: The HALP score appears to be a clinically useful and robust prognostic biomarker that may contribute to prognostic stratification and clinical decision‐making in super‐elderly patients with GC undergoing curative gastrectomy.

  • Open Access

    A Totally Laparoscopic Transhiatal Approach for Esophageal Cancer During Mediastinoscopic Esophagectomy

    by Hirotaka Konishi, Shutaro Sumiyoshi, Hiroyuki Inoue, Keiji Nishibeppu, Toshiyuki Kosuga, Yusuke Yamamoto, Ryo Morimura, Hitoshi Fujiwara, Atsushi Shiozaki

    Background: Mediastinoscopic esophagectomy is a minimally invasive approach that avoids thoracotomy and single-lung ventilation. We previously performed this procedure using hand-assisted laparoscopic surgery (HALS) and recently established a totally laparoscopic transhiatal approach. This retrospective, non-randomized study reported laparoscopic technique and compared the feasibility and surgical outcomes of these approaches. Methods: We retrospectively reviewed 262 patients who underwent radical mediastinoscopic esophagectomy using left cervical and transhiatal approaches at the Kyoto Prefectural University of Medicine between January 2020 and June 2026. HALS was performed in 202 patients and laparoscopy in 60 patients. Surgical procedures and perioperative outcomes were compared between the groups. Results: Blood loss and total operative time did not differ significantly between the groups, although the transhiatal procedure tended to require a longer operative time with laparoscopy (p = 0.09). The approach used for middle mediastinal lymphadenectomy was similar between the two groups (43% vs. 35%, p = 0.28), and the overall number of dissected lymph nodes, excluding the upper mediastinal and cervical nodes, was comparable. However, significantly more abdominal lymph nodes were dissected with laparoscopy than with HALS (17.9 vs. 15.7, p = 0.04). Laparoscopic gastric mobilization and lymph node dissection were safely performed, with no significant differences in the rate of postoperative complications or curability. Conclusions: The totally laparoscopic transhiatal technique is a feasible and safe approach for mediastinoscopic esophagectomy, with surgical outcomes comparable to those of HALS and not inferior abdominal lymph node dissection. It may be particularly advantageous for cases requiring meticulous abdominal lymphadenectomy.

  • Open Access

    Potential of clinical staging for long‑term prognosis prediction in pathological stage III gastric cancer

    by Naosuke Nakamichi, Hiroyuki Inoue, Takeshi Kubota, Toshiyuki Kosuga, Keiji Nishibeppu, Kazuya Takabatake, Shutaro Sumiyoshi, Junichi Hamada, Kento Kurashima, Hidemasa Kubo, et al.

    In gastric cancer (GC), discrepancies are often observed between the clinical stage (cStage) and pathological stage (pStage). Nevertheless, cStage diagnosis may contribute to outcome predictions even within the same pStage. Therefore, the present study examined the prognostic significance of cStage in patients with pStage III GC who underwent curative gastrectomy. A multicenter retrospective study was conducted on 162 patients with pStage III GC who underwent curative resection at three institutions in Kyoto between April 2010 and May 2020. Patients were stratified into two groups according to cStage (I/II vs. III/IVA), and the clinicopathological features and survival outcomes were compared. Of the 162 patients, 72 (44.4%) were classified as cStage I/II and 90 (55.6%) as cStage III/IVA. The 5‑year overall survival rate was significantly lower in the cStage III/IVA group than that in the cStage I/II group (50.0% vs. 63.9%, P=0.030), as was the 5‑year recurrence‑free survival rate (36.7% vs. 51.4%, P=0.023). A multivariate analysis identified cStage III/IVA (P<0.05, hazard ratio=1.912) as an independent poor prognostic factor for overall survival. In conclusion, preoperative cStage may serve as a complementary prognostic indicator reflecting tumor biological aggressiveness and could assist in postoperative treatment decision‑making.

  • Prognostic impact of the advanced lung cancer inflammation index in patients aged ≥80 years undergoing gastrectomy for gastric cancer

    by Yuta Marunaka, Hiroyuki Inoue, Takeshi Kubota, Toshiyuki Kosuga, Keiji Nishibeppu, Kazuya Takabatake, Atsushi Shiozaki

  • Tri‐Scenario‐Based MAICOHAN Strategy for Minimally Invasive Extended Left Hepatectomy

    by Yusuke Yamamoto, Ryo Morimura, Taisuke Imamura, Hidemasa Kubo, Rie Shibata, Hiroyuki Inoue, Kento Kurashima, Keiji Nishibeppu, Kenji Nanishi, Jun Kiuchi, et al.

    Background: Minimally invasive extended left hepatectomy (MI‐ExLH) remains a technically challenging procedure that is not yet standardized. Methods: We retrospectively reviewed cases of minimally invasive left hepatectomy (MI‐LH) and MI‐ExLH performed between 2018 and 2025 at a single institution. Surgical strategies were classified into three categories according to the tri‐scenario‐based MAICOHAN strategy ( M HV‐based A ssessment and I nvolvement/non‐involvement in C audate–hilum‐dependent O ptimal extended left H epatectomy A lgorithmic N avigation): (1) the cranio‐dorsal or cranio‐ventral approach, selected depending on the tumor‐middle hepatic vein (MHV) relationship, (2) the Arantius‐first or caudate lobe resection approach, chosen based on caudate lobe involvement, and (3) the liver‐transection‐first or left‐hepatic‐duct‐dissection‐first approach, based on the tumor‐left hepatic hilum relationship. We divided the cases into two groups—the MAICOHAN strategy group (MS group) and the non‐MAICOHAN strategy group (non‐MS group), where procedures were and were not performed according to the abovementioned scenarios, respectively. Results: Eleven MI‐LH and 12 MI‐ExLH cases were included (MS group, n = 11; non‐MS group, n = 12). Operative time and length of hospital stay were significantly shorter in the MS group than in the non‐MS group (262 vs. 376 min, p = 0.023; 6 vs. 9 days, p = 0.016). In the subgroup analysis restricted to MI‐ExLH cases, the incidence of positive surgical margins was significantly lower in the MS group (0% vs. 50%, p = 0.046). Conclusion: The tri‐scenario‐based MAICOHAN strategy provides a practical framework that may contribute to guiding surgeons in planning and performing MI‐ExLH more safely and consistently.

  • Open Access

    Endoscopic Features of Background Gastritis Associated With Remnant Gastric Cancer: A Multicenter Retrospective Study

    by Takuma Ohashi, Takeshi Kubota, Hayato Fukui, Osamu Dohi, Shuhei Komatsu, Yasuhiro Shioaki, Yasuhito Izumiya, Tetsuro Yamashita, Sachie Tanaka, Soujin Sai, et al.

    Ohashi T, et al. J Gastric Cancer. 2026 Apr;26(2):232-246. https://doi.org/10.5230/jgc.2026.26.e15


  • Open Access

    Continuous renal replacement therapy using a cellulose triacetate hemofilter for severe coronavirus disease

    by Kanako Takahashi, Hiroyuki Inoue, Masumi Kishimoto, Ryuichi Nakayama, Takehiko Kasai, Naofumi Bunya, Keisuke Harada, Shuji Uemura, Eichi Narimatsu

    Background: In patients with severe coronavirus disease (COVID-19), the use of acrylonitrile hemofilters can reduce cytokine concentrations. However, acrylonitrile hemofilters can easily coagulate, and the effect of hemofilters on improvement in patient prognosis remains unclear. Therefore, we aimed to investigate the changes in serum cytokine concentrations, alleviation of organ damage, and improvement in patient prognosis with continuous renal replacement therapy (CRRT) using a cellulose triacetate (CTA) filter with excellent anticoagulation property in patients with severe COVID-19. Methods: This was a retrospective, single-center study conducted by the Advanced Critical Care Center in Sapporo Medical University Hospital, Japan. Seven patients with severe COVID-19 between March 01 and June 30, 2020, were included. The patients were under mechanical ventilation and received continuous blood purification therapy with a CTA filter. We summarized the CRRT status and patient prognosis and measured their serum cytokine (interleukin [IL]-1β, IL-4, IL-6, IL-8, IL-10, tumor necrosis factor-α, and interferon-γ) and serum marker levels, before and after CRRT. In addition, we evaluated the changes in their respiratory status, hemodynamics, and organ dysfunction scores. The average age of the patients was 61.5 years, and five patients were male. Extracorporeal membrane oxygenation was used in five patients. The treatment outcome included three deaths. Results: The median CRRT duration was 7 days. The hemofilter was replaced once a day. After CRRT, the IL-6 concentration decreased from 393 to 85 pg/mL (p = 0.016), the Krebs von den Lungen-6 concentration decreased from 554 to 350 U/mL, and the PaO2/FiO2 ratio increased significantly from 90 to 248, and therefore, oxygenation improved. In addition, the norepinephrine dose and lactate level decreased, and the circulation tended to improve; however, the renal function and Sequential Organ Failure Assessment score did not change. Conclusions: The serum IL-6 level decreased, and the respiratory status improved upon CRRT using a CTA filter in patients with severe COVID-19.

  • ASO Author Reflections: NADPH Oxidase 2 has Potential as a Therapeutic Target for Esophageal Squamous Cell Carcinoma

    by Hiroki Shimizu, Keita Katsurahara, Hiroyuki Inoue, Atsushi Shiozaki, Eigo Otsuji

  • ASO Visual Abstract: Functions and Clinical Significance of CACNA2D1 in Gastric Cancer

    by Hiroyuki Inoue, Atsushi Shiozaki, Toshiyuki Kosuga, Hiroki Shimizu, Michihiro Kudou, Takuma Ohashi, Tomohiro Arita, Hirotaka Konishi, Shuhei Komatsu, Takeshi Kubota, et al.